Figure 3

Kaplan–Meier estimates of overall survival in advanced gastric cancer patients receiving only first-line FOLFOX chemotherapy according to (A) MMSET and (B) UBC9 mRNA expression levels.
Kaplan–Meier estimates of overall survival in advanced gastric cancer patients receiving only first-line FOLFOX chemotherapy according to (A) MMSET and (B) UBC9 mRNA expression levels.